Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-048515
Filing Date
2012-08-29
Accepted
2012-08-29 09:56:00
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A v321272_10qa.htm 10-Q/A 21162
  Complete submission text file 0001144204-12-048515.txt   6484879

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT bcli-20120630.xml EX-101.INS 1128256
3 XBRL TAXONOMY EXTENSION SCHEMA bcli-20120630.xsd EX-101.SCH 84040
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20120630_cal.xml EX-101.CAL 34800
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20120630_def.xml EX-101.DEF 249291
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20120630_lab.xml EX-101.LAB 428499
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20120630_pre.xml EX-101.PRE 285955
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-54365 | Film No.: 121061716
SIC: 2836 Biological Products, (No Diagnostic Substances)